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The mini
internship for
non-physicians took place on October
19 and 20 and was very successful.
Board members and other volunteers
participated in activities ranging from
rounds to operating room observation.
At a subsequent dinner meeting to _
review the results of the program, all
participants expressed satisfaction with
their experiences. Most said they
gained valuable knowledge about
hospital functioning and the daily
responsibilities of our Medical Staff.
The Ad Hoc HIV Committee recently
met to continue its work on developing
a policy that would ensure prompt and
confidential testing for our Medical
Staff, particularly after potential
exposures. The mechanics of such a
program have now been developed,
and a formal policy will soon be
recommended to deal with this
potentially troublesome problem.
The Physician Well-Being Group
continues to meet regularly, having
completed another full cycle. Surveys
of the individuals who participated
have indicated a very high level of
satisfaction with these bi-weekly
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sessions. These sessions have dealt
with all types of stressful workplace
problems for the Medical Staff.
The program has not been designed to
address either substance abuse or other
major adjustment problems which
could require professional counseling.
Other avenues of intervention for these
more serious problems are being
explored, comparable to the Employee
Assistance Program.
Finally, the future has definitely
arrived in the form of data availability
from the Pennsylvania Health Care
Cost Containment Council. The
Council is preparing to release for the
frrst time physician-specific
information, using cardiovascular
surgery statistics. All of these data
will presumably be made public soon.
How meaningful and useful this
information will be for the lay public
remains very much in questions.
Best wishes for a Happy Thanksgiving!

Neurologist to Serve as
President-Elect
John E. Castaldo, M.D., neurologist,
was recently nominated and elected to
serve as Medical Staff President-elect
for a two-year term beginning January
1, 1993.
Dr. Castaldo joined the Medical Staff
in 1983, and is a member of the
Department of Medicine, Division of
Neurosciences. A graduate of
Dartmouth Medical School, Hanover,
N.H., Dr. Castaldo completed one

Physician Well-Being
Group
FACT: Research identifies that the
stressor most frequently cited by
physicians is the pressure of time.
When compared with workers in other
occupations, three times as many
physicians spend 60 hours or more a
week on the job. Claims of clinical
excellence are often made on the basis
of the doctor's willingness to work
harder and do more than his/her
colleagues.
FACT: Research indicates the second
most frequently cited source of stress is
the doctor/patient relationship.
However, in a recent study, 51.5% of
the male physicians noted the strain of
relationships with patients whereas only
17.9% of the female physicians did.

year of training in Medicine at
Dartmouth-Hitchcock Medical Center
where he also completed a three-year
residency in Neurology. Dr. Castaldo
is certified in Neurology by the
American Board of Psychiatry and
Neurology.
Dr. Castaldo is a member of Lehigh
Neurology, located at 1210 S. Cedar
Crest Boulevard, Allentown.
He and his wife, Nancy, reside in
Wescosville with their three sons,
David, Mark, and Nicholas.
Collegial support systems continue to ·
be one of the most effective means of .
coping with physician stress. One of
the purposes of the Physician WellBeing Group is to assist in developing
different and more effective ways of
coping with stressors. Listening to
colleagues express the same sense of
frustration, anxiety and doubt is often
healing in its own right; one genuinely
hears, "I am not alone."
We invite your interest and
participation. If you would like more
information about the group, please
contact Robert M. Post, M.D., at 4331622, or John C. Turoczi, Ed.D., at
481-9161. All inquiries are
confidential, and the group functions
with a strict code of confidentiality.

FACT: A recent research study
indicated that the psychologic
symptoms of physicians sued for
malpractice included: psychological
trauma, job strain, shame/doubt, and
active coping.
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Pre-Admission Central
Document Processing
In order to improve efficiencies with

physicians and their office staffs by
reducing paper trails and telephone
calls required when admitting patients,
Lehigh Valley Hospital has developed
a new program known as PreAdmission Central Document
Processing. This new program will
provide a centralized location at both
hospital sites (17th & Chew and Cedar
Crest & 1-78) to receive, track, and
compile all documents required for
Pre-Admission chart completion. This
department will be designated as
Central Document Processing (CDP).
Implementation of CDP at 17th &
Chew is scheduled for November 23,
1992, and at Cedar Crest & 1-78 on
January 18, 1993.
The advantages of CDP include: a
single repository for pre-admission
documents, elimination of lost
documents, well-defined process to
meeting customer requirements, and
assurance that all required patient
documents (including active, old, or
clinic records) are collected and
available prior to admission.
Specific physician office requirements
necessary to ensure CDP success are as
follows:

o Pre-admission histories and
physicals and consultations be dictated
via Lehigh Valley Hospital dictation
system within 48 hours prior to date of
admission.

o Histories and physicals, consultations, consents, letters, and other
documentation required for the
admission be submitted to CDP by 8
a.m. the day prior to admission.
Physician offices will be notified
initially of missing or incomplete
documents 72 hours prior to admission.
Offices will again be notified 48 hours
prior to admission of missing or
incomplete documents.
Providing complete and accurate
documentation prior to admission will
enhance patient satisfaction, provide
quality patient care, and avoid delays
created as a result of incomplete or
missing documentation.
A special Physician· Office Practice
Forum has been scheduled on
Monday, November 16, from noon to
2 p.m., in the Auditorium at 17th &
Chew Streets, to review details for
this new program. As lunch will be
provided, registration is required. To
register, please contact Janet M.
Laudenslager, Coordinator, Physician
Office Practice Services (POPS), at
402-2780.

o Pre-admission testing recommended
on all patients at least 96 hours prior to
date of admission.
o Pre-admission test results from nonLehigh Valley Hospital labs and
physician offices must be submitted to
CDP 72 hours prior to date of
admission.
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Consultations and
Patients Admitted to the
Hospital from the
Emergency Room
In order to expedite patient care and as

a courtesy to the time and schedules of
your fellow physicians, please comply
with the following suggestions.
When you are admitting a patient from
the Emergency Room to the hospital
and wish to consult another physician
which may cause a delay in the patient
being moved to their assigned bed,
please:

Microbiology/Virology

News

On Monday, October 26, the new
Microbiology-Virology Request Form
No. LAB-14 was distributed for all
exam requests. This form should be
used exclusively for all Microbiology
and Virology test requests.
Please note the following guidelines
when submitting specimens to the
laboratory:

o Do not use Lab Requestion (Fluids)
LAB-61 for ordering Microbiology or
Virology cultures, e.g., CSF
specimens. Use only Form No. LAB14.
o For optimal virus recovery from
CSF, place the specimen in a separate.
sterile red top Vacutainer tube and
submit on wet ice. CSF for bacterial
culture must not be submitted on ice.

o be sure to write an order for the
consultation on the order sheet in the
Emergency Room, and be sure the
nurse or ward clerk sees the order so
that they will call the consultant's
office; and
o whenever possible, in keeping with
good medical practice, personally
contact the consulting physician to
inform that individual of the patient's
status, what you want from the
consultation, and the urgency of the
consultation.

o When ordering Virus Isolation
exams, complete a Virology History
Form No. LAB-21 to ensure optimal
recovery of the etiologic agent.
o Ensure sufficient specimen is
submitted for the exams requested,
e.g., >5 ml CSF for TB, Fungus, and
routine culture. NOTE: Tissue
rather than swabs are preferred for
culture and stain requests.
o Ensure appropriate use of
Microbiology and Virology specimen
collection containers. Please refer to
the Microbiology-Virology Specimen
Collection and Transport Policy
and/or photograph of appropriate
specimen containers posted on each
nursing unit.
If you have any questions, please
contact Diane C. Halstead, Ph.D.,
Director of Microbiology/Virology, at

402-8150.

Continued on Page 5
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Monitoring of Warfarin
(Coumadin) Therapy
Recently, there have been some
changes recommended as far as the
intensity of oral anticoagulation for
common conditions utilizing Warfarin
(Coumadin) Therapy. A specific
reference can be found in Chest
Volume 102, #4, October, 1992.' The
recommended therapeutic range for all
anticoagulant therapy can be found on
Table 2 on Page 317S. A summary of
the changes are as follows:

INDICATION

PT(SEC) PI'R INR

Recurrent
Embolism

18-23

1.5-1.8

Mechanical
Valve

21-25

1.7-2.0 2.5-3.5

2-3

PTR - PT Patient/PT Control in Seconds
INR - PTR raised to the power of the
thromboplastin lSI
lSI= 1.84

For a Mechanical Valve, this
represents a decrease in the INR, from
the previously recommended level of 34.5 to the 2.5-3.5 version.

The Library is currently attempting to
identify medical jouqtals which are
available in CD-ROM format.
If you come across any advertisements
for these in the mail or in your
professional journals, please send them
to Sherry Giardiniere, Health Sciences
Library, Cedar Crest & 1-78.
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Review of Antibiotic
Prescribing Practices at
Lehigh Valley Hospital
The Clinical Pharmacy, in conjunction
with Infectious Diseases, have targeted
five antibiotics, based on cost and
usage, for review. The five antibiotics
under review include: Ceftazidime IV
'
Ciprofloxacin, Ceftriaxone,
Ampicillin/Sulbactam, and Aztreonam.
The review criteria are based on the
usage guidelines printed on the back of
the Parenteral Antibiotic Order Sheet
(PAOS). Usage evaluation data has
been compiled for July/August and
September, 1992. The results have
been consistent through the evaluation
periods.
Ceftazidime usage predominantly fell
into the empiric category with 55% to
76% of therapy for suspected
Pseudomonas aernginosa infections or
neutropenic fever. The suggested
usage guidelines for ceftazidime
recommend its use for aerobic gramnegative bacilli resistant to cefazolin
(i.e., Enterobacter or Serratia) at
dosages of 1Gm IV QSH; and
Pseudomonas aernginosa at dosages
of 2Gm IV Q8H, when piperaclllin
and/ or aminoglycoside is not
appropriate (allergy or resistance).
A high incidence of empiric IV
ciprofloxacin use was also observed
with 46.7% to 64% of patients treated
outside the suggested usage guidelines.
IV ciprofloxacin is a very costly
antibiotic and its use should be limited
to resistant aerobic gram-negative
bacilli (i.e., Pseudomonas,
Enterobacter, Serratia) based on the
patient's culture and susceptibility

results. Ciprofloxacin, or any of the
quinolones, should not be used if a
Staph, Strep, or an anaerobic infection
is suspected.
One empiric regimen for a suspected
gram-negative bacilli infection would
be piperacillin +1- an aminoglycoside.
If Pseudomonas is a concern, the
piperacillin dose should be 5Gm IV
QSH plus an aminoglycoside. If the
patient is penicillin allergic and empiric
treatment for a gram-negative infection
is warranted, ciprofloxacin or
ceftazidime, if the patient has tolerated
cephalosporins by history, can be used
as alternatives to piperacillin therapy.
Twenty to 25% of all ceftriaxone
orders received by the Pharmacy
continue to be for a Q 12H dosing
interval. The majority of these patients
were being treated with ceftriaxone
Q12H for pneumonia. Ceftriaxone
lGm Q24H maintains serum
concentration above the MIC90 of
susceptible pathogens, and is adequate
therapy except in documented or
suspected CNS infections where Q12H
dosing is warranted.
Ampicillin/Sulbactu.n (Unasyn) use fell
within the suggested usage guidelines
with the majority of its use seen in
mixed bacterial infections (i.e.,
diabetic foot): The only concern
observed during the review was the
number of patients with Unasyn orders
who were penicillin allergic
warranting calls to the prescribing
physician by the pharmacist.
Continued on Page 7
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The use of aminoglycosides is on the
decline at Lehigh Valley Hospital with
aztreonam usage soaring for a "renal
sparing" effect. During the months of
July through September, 56.3% to
69.2% of all aztreonam orders were
for its "renal sparing" effect, however,
greater than 50% of the patients treated
with aztreonam had creatinine
clearances of 2._50ml/min.
Aztreonam, as well as numerous other
agents, may be useful in renal failure
(SCr 2. 2-3mg/dL) as an
aminoglycoside sparing agent. Also,
aminoglycosides can be safely dosed
according to renal function and may
offer a more cost effective alternative
to aztreonam especially in empiric
therapy.

National Association of
Medical Staff Services
Week Observed
This year, the week of November 2
was set aside by the National
Association of Medical Staff Services
(NAMSS) to recognize the
contributions of medical staff services
professionals across the nation. In
addition, Congress approved a
resolution supporting NAMSS week,
and the Governor of Pennsylvania,
each year for the past three years, has
issued an official proclamation for
Pennsylvania Association of Medical
Staff Services (PAMSS) Week.
Medical Staff Services professionals
are responsible for credentialing
physicians and allied health
professionals for appointment and
reappointment, and for assuring that
the Medical Staff and the Hospital are

The drug usage review of ceftazidime,
ciprofloxacin IV, ceftriaxone,
ampicillin/sulbactam, and aztreonam
will continue on a monthly basis.
Criteria used for the review are based
on the suggested usage guidelines. The
Pharmacy, in conjunction with
Infectious Diseases, would like to see
improved compliance with the PAOS
and adherence to the usage guidelines.
If you have any questions regarding
this issue, please contact James A.
Giardina, Director, Pharmacy, at
402-8880.

in compliance with regulations
governing medical staff activities which .
are mandated by the federal
government, Joint Commission on
Accreditation of Healthcare
Organizations, Pennsylvania
Department of Health, and other
regulatory bodies. These individuals
also provide administrative and clerical
support to the Medical Staff in its
multitude of activities.
The Medical Staff Services Office at
Lehigh Valley Hospital includes
Elizabeth A. Ehnot, Medical Staff
Receptionist; John W. Hart, Vice
President; Eileen E. Jobst, Medical
Staff Secretary; Rita M. Mest, CMSC,
Medical Staff Coordinator; and Sally
Roessler, Executive Secretary. These
individuals provide service to Lehigh
Valley Hospital's 722-member Medical
Staff (with 30 standing committees),
and 155-member Allied Health staff.
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New Edition of Medical
Staff Directory Available
The Medical Staff Services Office
recently issued the annual edition of
the Medical Staff Directory and
Departmental Rosters. This valuable
resource includes the Medical Staff
directory, membership rosters of
departments/divisions/ sections,
identifying Board Certification attained
by these members, listing of Medical
Staff members by practice name, and
an Allied Health Professionals
directory.
These books have been distributed to
the Medical Staff and each hospital
department.

Families in Transition
Update
Judy Braun, Case Manager for
Families in Transition, reports that the
physician participation in the program
has been greatly appreciated by the
enrollees and their families.
Unfortunately, there have been some
delays in payment of physicians' bills.
In order to expedite the processing of
claims, please use either Form HCFA1500 (1-84) or Form HCFA-1500 (1290), and provide the following
information on the form:
o
o
o
o

subscriber's Social Security Number
patient's name
date of service
diagnosis on each bill

Please Note: Each directory holder
is responsible for updating the
directory each month with changes
provided in Medical Staff Progress
Notes.
In an effort to reduce waste, each
physician practice and hospital
department should have received one
copy. If additional copies of portions
of the document are needed,
physicians' offices and departments are
encouraged to duplicate those portions
as desired. If additional copies of the
entire document are needed, please
contact Medical Staff Services at
402-2244.

o procedure numbers for each
individual service (CPT)
o provider of service tax.I.D. number
and address
o place of service
o amount charged for each service
o patient account number (if
applicable)
o drug names for prescriptions (not
just Rx number)
o date of birth of patient (some family
members have the same frrst name)
o assignment of benefits in box 13 on
HCFA form
If you have any questions regarding
this issue, please contact Gloria Gelfo
at Spectrum Administrators at
402-7410.
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New President Named for
Trust Fund
George J. Lukac was recently named
President of Lehigh Valley Trust Fund
and Vice President for Development,
Lehigh Valley ·Health Network.

He has 31 years of experience in all
areas of fund raising and institutional
advancement, including 15 years as a
senior executive.

Prior to his new post, Mr. Lukac was
president and chief executive officer of
the Venice Hospital Foundation, which
supports a 342-bed hospital in Venice,
Florida.

Mr. Lukac's office will be in the
Development Suite located at 1243 S,
Cedar Crest Boulevard, and his
telephone number is 402-3090.

Home Portrait Special
Offer
The holiday season is just around the
corner and soon you will be thinking
about gift ideas for those special people
in your life. The Arts Advisory
Council for Lehigh Valley Hospital has
a special gift idea for you. Give
someone a gift that will be treasured
and enjoyed for years to come -- an
original watercolor of their home. Get
together with your brothers, sisters,
aunts or uncles to purchase a special
family heirloom for your parents,
grandparents or in-laws.
The Arts Advisory Council promoted
this offer two years ago with great
success. Many employees, physicians,
and other friends of the hospital took
advantage of this special offer and
were extremely pleased with their
home portraits. The great news is that
the prices have not increased since that
time.

With a special gift certificate available
from the Arts Advisory Council, you
can have a beautiful 14" x 18"
watercolor, matted and framed,
delivered to your door for only $195.
Painted from a photograph, your
portrait comes with a 100% satisfaction
guarantee.
Hurry! If you act now, your home
portrait can be delivered in time for the
holidays. For more information and to
obtain special savings on a home
portrait, contact Gail Evans of the Arts
Advisory Council at 402-3031.
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Pool Trustees Approve
Funding to Hospital
At the September meeting of the
Dorothy Rider Pool Health Care Trust,
the Pool Trustees approved funding of
$197,360 for a two-year program titled
Health Care Career Development
Programs n. This program is a
continuation of Lehigh Valley
Hospital's effort to consolidate five
different types of educational programs
in one office: the Work/Study
Program, the Nursing Tuition
Assistance Program, the
Professional/Technical Tuition
Assistance Program, the Pool Trust
Scholars, and the Graduate Education
Program for Clinical Nurses. These
programs are coordinated by Denise
Holub.
Also approved was funding of Spirit of
Women 1993 for $10,000 to support a
conference to be held in March, 1993.
The conference is sponsored by
WomanCare, a program of Lehigh
Valley Hospital. Speakers for the
event will be Frances Hesselbein,
President and CEO of the Peter F.
Drucker Foundation for Nonprofit
Management; Ellen Goodman, the
Pulitzer Prize winning journalist; and
Jane Tear, an author on issues
concerning women and
communications.

The release of $22,589 of previously
committed Consultation/Liaison
Psychiatry funds to support the
recruitment process of two staff
psychiatrists and one staff doctoral
psychologist by Michael W.
Kaufmann, M.D., Chairman,
Department of Psychiatry, was also
approved.
Two Research Advisory Committee
approved protocols were approved for
funding out of the Institutional
Research program under the direction
of James F. Reed, Ph.D., Director of
Research. The protocols approved for
funding were Neurotoxicity of Human
Tissue Ribonuclease IIN, principal
investigator- Brian W. Little, M.D.,
Ph.D., and co-investigators- Jack A.
Alhadeff, Ph.D., Vassie Ware, Ph.D.,
and Neal Simon, Ph.D., for $19,400;
and Cognitive Restructuring,
Meditation Training and Stress
Management Intervention in Cardiac
Rehabilitation, principal investigator Judith I. Pool, M.Ed., for $12,715.

The Trustees approved funding of up
to $10,000 to support the Recruitment
of the Chairman of the Department
of Emergency Medicine. These funds
were approved to secure the
consultants who would serve as
facilitators in this important process.
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Congratulations!
Joseph Kavchok, Jr., M.D.,
ophthalmologist, recently passed the
certification examination and is now a
Diplomate of the American Board of
Ophthalmology.
John D. Nuschke, Jr., M.D., general
internist, was recently informed by the
American Board of Internal Medicine
that he successfully passed the
Geriatric Medicine examination and is
now certified as a Diplomate in
Geriatric Medicine.

Publications, Papers and
Presentations
Kevin J. Farrell, M.D.,
trauma/bum/critical care surgeon, was
a guest speaker at the 45th Anniversary
Symposium of the U.S. Army Institute
of Surgical Research where he
presented information about· the
regimen of care he developed for
elderly bum patients.
Peter A. Keblish, M.D., chief of
Orthopedic Surgery, was a special
guest lecturer for the Korean
Orthopaedic Knee Society in Seoul,
Korea, in early October. His
presentations included Arthroscopic
Treatment of the Meniscal
Pathology, Long-term LCS Followup, and Patellar Retention vs.
Patellar Replacement.
On Tuesday, October 13, Dr. Keblish
was an invited speaker at The Score
on Health (Featuring a Medley of
Topics for Older Adults), sponsored

Peter F. Rovito, M.D., general
surgeon, was recently notified that he
has been granted the status of Initiate
as described in the Fellowship
Requirements of the American College
of Surgeons.
.
Francis A. Salerno, M.D., chief of
Geriatrics, has been elected to
Fellowship in the American College of
Physicians, the professional
organization of internists.

by Lehigh Valley Hospital's Prestige
Health in conjunction with St. Luke's
Hospital's Geriatric Services, and held
at Lehigh University's Mountaintop
Campus. He presented an Arthritis
workshop, providing· an overview of
orthopedic management of arthritic
joints and an update on joint
replacement technology.

Indru T. Khubchandani, M.D.,

colon-rectal surgeon, was an invited
speaker at the 41st Annual Congress of
Brazilian Society of Colon and Rectal
Surgeons at Pocos de Caldas, a resort
near Sao Paulo, Brazil, from
September 27-30.
Dr. Khubchandani delivered the Harry
E. Bacon Oration titled Is Radical
Excision Extinct for Cancer of the
Rectum? He also participated on a
panel on inflammatory bowel disease
and gave two lectures on Fistula in
Ano and Paracolostomy Hernias.
Continued on Page 12
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Dr. Khubchandani also examined
candidates for the American Board of
Colon and Rectal Surgery in Chicago,
ill., on September 18 and 19. The oral
examination certifies candidates who
have passed the American Board of
General Surgery and the written
examination portion of the American
Board of Colon and Rectal Surgery.

Nelson P. Kopyt, D.O., nephrologist,
co-authored an article, Fluid,
Electrolyte, and Acid-Base Disorders
Complicating Diabetes Mellitus,
which was published in Diseases of the
Kidney, Fifth Edition.
Brian W. Little, M.D., Ph.D.,
neuropathologist, co-authored an
article, Atypical Creu~eldt-Jakob
Disease in an American Family with
an Insert Mutation in the PRNP
Amyloid Precursor Gene, which was
published in the February 1992 issue of
NEUROLOGY.
Robert X. Murphy, Jr., M.D.,
plastic surgeon, presented a paper titled
Magnetic Resonance Imaging in the
Evaluation of Persistent Carpal
Tunnel Syndrome at a meeting of the
Northeastern Society of Plastic
Surgeons held recently in Bermuda.
Lester Rosen, M.D., colon-rectal
surgeon, recently attended a meeting in
Washington, D.C., which was
sponsored jointly by the Agency for
Health Care Policy and Research
(AHCPR) and the American Medical
Association (AMA) for the purpose of
defining digestive disorder topics for
AHCPR facilitated clinical practice
guidelines which would be sponsored
by the AMA.

The meeting was represented by over
20 participants from digestive
organizations including the American
Society of Colon and Rectal Surgeons1
the American Gastroenterological
Association, the American College of
Physicians, the National Institutes of
Health, and the G .I. drug branch of the
FDA.
After looking at 15 digestive disorders5
the overwhelming consensus of the
committee was to rank Colorectal
, Neoplasia Screening as the number one
priority for convening expert panels
and/or federal contracts for 1993.
Other areas in the top five were End
Stage Liver Disease, Enteric
Infections 1 Peptic Ulcer, and
Gastrointestinal Reflux.
Dr. Rosen is Chairman of the
Standards Task Force of the American
Society of Colon and Rectal Surgeons,
and will be a member of the panel to
investigate Colorectal Cancer
Screening.

November 19: The
Great American
Smokeout - A day
observed annually -~
the third Thursday
in November --.to
encourage smokers to kick
the habit for at least 24
hours. Sponsored by the
American Cancer Society.
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Upcoming Seminars,
Conferences, and
Meetings

Regional Symposium
Series IV
Second Annual Musculoskeletal
Sciences Symposium: Upper
Extremity Injuries in the Athlete will
be held on Saturday, December 12,
from 7:45a.m. to 12:30 p.m., in the
Auditorium of Lehigh Valley Hospital,
Cedar Crest & 1-78.
At the completion of the program,
participants should be able to describe
the symptoms, treatment, and
rehabilitation process of shoulder,
elbow, and hand injuries in the athlete.
Orthopedic surgeons, general
practitioners, physicians' assistants,
physical therapists, coaches, trainers,
and others interested in an update on
upper extremity injuries in the athlete
will benefit from the program.
For more information, please contact
Human Resource Development at
402-8322.

Pharmacology, University of Medicine
and Dentistry of New Jersey-Robert
Wood Johnson Medical School, New
Brunswick, N.J., on Tuesday,
November 24.
Medical Grand Rounds are held each
Tuesday beginning at noon in the
Auditorium of Lehigh Valley Hospital,
Cedar Crest & 1-78.
For more information, call the
Department of Medicine at 402-8200.

Department of Pediatrics
Treatment of Shock in Children will
be presented by Steven Lucking,
M.D., Chief, Division of Critical
Care, Hershey Medical Center, on
Friday, November 20, at noon, in the
Auditorium of Lehigh Valley Hospital,
17th & Chew.
For more information, contact Beverly
Humphrey in the Department of
Pediatrics at 402-2410.

Psychiatric Grand
Rounds

The Behavioral Manifestations of
Medical Dlness in the Elderly will be
presented by Joel E. Streim, M.D.,
Section of Geriatric Psychiatry, Ralston
Penn Center, Philadelphia, Pa., on
Tuesday, November 17.

Management of Tardive Dyskinesia
will be presented by Vernon Neppe,
M.D., Ph.D., F.R.C.P.C., F.F.
Psych., Director of the Division of
Neuropsychiatry, University of
Washington Harborview Medical
Center, Seattle, Wash., on Thursday,
November 19, at noon, in the
Auditorium of Lehigh Valley Hospital,
17th & Chew.

Update on Scleroderma will be
presented by James R. Seibold, M.D.,
Director of Clinical Research Center,
and Director, Program in Clinical

As lunch will be provided, reservations
are requested., For more information
or to register, please call Lisa in the
Department of Psychiatry at 402-2810.

Medical Grand Rounds
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• For Sale or Lease -- MedicalProfessional Office Building on Cedar
Crest Boulevard. just minutes from Cedar
Crest & 1-78 and 17th & Chew. Plerrty of
parking. Ideal for physician.
• For Sale or Lease - Springhouse
Professional Center. 1575 Pond Road.
Ideal for physician's office.
Approximately 2.500 sq. ft. Will finish
space to specifications.

* For Sale or Lease - Medicalprofessional office building on South
Cedar Crest Boulevard. just minutes from
Cedar Crest & 1-78 and 17th & Chew.
3,560 total sq. ft. Ample parking,
security/fire alarms installed. Ideal for
.Physician group.
• For Sale -- Professional Office Building
on West Broad Street. near the
Allentown/Bethlehem border. 4.500 sq.
ft. with plenty of parking on corner lot.

• For Lease -- Slots are currently
available for the Brown Bag suite at
Kutztown Professional Center.
• For Lease -- Share large medical office
near Cedar Crest & 1-78. Fully furnished
and staffed. Multiple line phone system.
Computerized billing available.
• For Lease -- Specialty practice timeshare space available in a comprehensive
health care facility. Riverside Professional
Center. 4019 Wynnewood Drive. Laurys
Station. Half- or full-day slots
immediately available.
• For Lease - Share medical office spac&
at Riverside Professional Center in Laurys
Station. Ideal for solo or small group
practice .
For more information or for assistance in
finding appropriate office space to meet
your needs. contact Joe Pilla. POPS
Representative, at 402-9647.

WHO'S NEW
This section of Medical Staff Progress
Notes contains an update of new
appointments, address changes, newly
approved privileges, etc. Please
remember that each department or unit
is responsible for updating its
directory, rolodexes, and approved
privilege rosters.

Medical Staff
Appointments
Sheldon H. Linn, MD

{Valley OB-GYN Associates Ltd. - Glazerman)

322 S. 17th Street
Allentown, PA 18104-6734
(215) 434-4015
Department of Obstetrics and
Gynecology
Division of Obstetrics/Gynecology
Section of Benign Gynecology
Provisional Active

Nathan Schwartz, MD
(Yasin N. Khan, MD)

1251 S. Cedar Crest Blvd.
Suite 102B
Allentown, P A 18103
(215) 402-8216
Department of Anesthesiology
(Pain Management)
Provisional Active

Nancy K. Spangler, MD
(Healthy Business- Burtaine)

1251 S. Cedar Crest Blvd.
Suite 103C
Allentown, PA 18103
(215) 435-1151
Department of Medicine
Division of General Internal Medicine
Provisional Referring
Continued on Page 15
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Appointment of Members
Assigned to New Division of
Geriatrics
Francis A. Salerno, MD
Chief
Division of Geriatrics
David P. Carney, MD
Associate Chief
Division of General Internal
Medicine/Geriatrics
Sam Bub, MD
Division of Family Practice/Geriatrics
David M. Caccese, MD
Division of General Internal
Medicine/Geriatrics
Jose R.· Garcia, MD
Division of General Internal
Medicine/Geriatrics
Gene H. Ginsberg, MD
Division of General Internal
Medicine/ Geriatrics
Charles A. Gordon, MD
Division of General Internal
Medicine/ Geriatrics
Jay E. Kloin, MD
Division of General Internal
Medicine/Geriatrics
GlennS. Kratzer, MD
Division of General Internal
Medicine/Geriatrics
Dennis M. McGorry, DO
Division of Family Practice/Geriatrics

Yehia Y. Mishriki, MD

John D. Nuschke, MD
Division of General Internal
Medicine/Geriatrics
Jon H. Schwartz, MD
Division of General Internal
Medicine/Geriatrics
Steven A. Scott, MD
Division of General Internal
Medicine/Geriatrics
Nancy A. Urankar, MD
Division of General Internal
Medicine/Geriatrics

Change of Division
Kamalesh T. Shah, MD
Department of Surgery
From Division of General
Surgery/Trauma to Division of General
Surgery/Trauma/Critical Care
Section of Surgical Oncology

Change of Status
Dale T. Bowen, MD
Department of Medicine
Division of Family Practice
From Active to Referring
Frank G. Finch, MD
Department of Medicine
Division of General Internal Medicine
From Active to Courtesy
David C. Hay, Sr., DPM
Department of Surgery
Division of Orthopedic Surgery
Section of Podiatry
From Consulting to Emeritus
Consulting
Continued on Page 16

Division of General Internal
Medicine/Geriatrics
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Joseph A. Miller, MD
Department of Obstetrics and
Gynecology
From Active to Emeritus Active
Alan N. Morrison, MD
Department of Medicine
.
Division of Hematology/Medtcal
Oncology
From Courtesy to Emeritus Courtesy
Charles C. Norelli, MD
Department of Medicine
Division of Physical
Medicine/Rehabilitation
From Active to Courtesy
Jo-Anne A. Steward, MD
Department of Medicine
. .
Division of General Internal Med1cme
From Provisional Courtesy to
Provisional Referring

Change of Address
Parkland Family Health Center
John D. Farrell, MD
Susan E. Kostenblatt, MD
Jack A. Lenhart, MD
Harvey B. Passman, DO
4520 Park View Drive
Schnecksville, PA 18078

Stanley Snyder, MD
GYN Clinic
17th & Chew
P.O. Box 7017
Allentown, PA 18105-7017
(215) 402-2860
Andrew B. Walker, MD
W.C. Payne Bldg., Suite 314
5149 N. 9th Avenue
Pensacola, FL 32504

Additional Privileges
Clarence A. Holland, Jr., MD
Department of Surgery
Division of General Surgery
Laparoscopic Surgical Privileges
J. Patrick Kleaveland, MD
Department of Medicine
Division of Cardiology
Directional Coronary Atherectomy
(DCA)

Resignation
Charles R. Shuffelbottom, DMD
Department of Dentistry
Division of General Dentistry
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The following actions were
taken at the October 12, 1992,
P & TCommittee meeting.
James Giardina, RPh.,
Director, Pharmacy.

P&T Highlights
Formulary Addition Requests Approved
Finasteride (Proscar, Merck)- a 5-alpha-

specific antigen (PSA) levels even in the
presence of prostatic cancer. Because of this
interference, all patients on finasteride should
undergo a digital exam prior to, and periodically while on the drug.

reductase inhibitor, is indicated in the treatment of benign prostatic hyperplasia (BPH).
Finasteride is a non surgical treatment for
BPH patients. 5-alpha-reductase is the
enzyme responsible for the conversion of
testosterone to dihydrotestosterone, which is
the principal androgen responsible for
prostate growth.

Oral bioavailability is approximately 63% and

is unaffected by food. Elimination is primarilyvia the renal route. However, renal
insufficiency has no effect on finasteride's
phannacokinetics. Several studies show that
finasteride reduces enlarged prostate tissue.
Mean maximum urine flow increased and
mean symptom scores decreased within 2
weeks in the finasteride treated group vs
controls. Some of these differences became
statistically significant, but a majority of
patients treated for one year did not have a
clinically significant increase in urinary flow.

Adverse reactions include impotence, decreased libido, decreased ejaculate volwne
and headache. Additionally, finasteride may
cause abnormal development of the male
fetus if pregnant women are exposed to
finasteride via crushed tablets or semen
containing the drug. Consequently, wumen
who are pregnant or may become pregnant
should avoid contact with crushed tablets and
exposure to semen ofa patient receiving

ftnasteride.

Finasteride markedly decreases prostate-

No significant interactions have been identified with finasteride. The recommended
dose of finasteride is Smg daily. Treatment
may need to be continued for at least six
months to assess response. Long term safety
has not been established.

Miscellaneous Agents
The following five medications were approved for addition to the formulary. These
medications are used primarily at 17 & Chew
for dermatologic conditions or epileptic

disorders in children. Due to the large
number and similarity to other formulary
agents, limited data is provided. Please
consult other references for more information
regarding prescribing, side effects, etc.

Generic Name

Brand Name

Category

Hydrocortisone Lotion 2.5%

Hytone

Topical Corticosteroid

Lactic Acid Lotion 12%

Lac-Hydrin

Emollient

Divalproex Sodium 125 mg

Depakote Sprinkles

Antiepileptic

Tretinoin Cream/Gel 0.025%

RetinA

Acne Product

Mephobarbita132mg

Mebaral

Barbiturate

.

-~
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Tara, Tara, Taradol!

Drug Use
Evaluation

Criteria were aooroved for an uocomimr
4

~~

~

study ofK.etorolac injection (foradol,
Syntex). Dosage and length of therapy will bf'
mnnttnrPrl 'lCMtnC:t' Pc:MhJic:hPrl rrttPn'l
···-·------o-·~- ~~-----~- -·--·-·

Ketorolac Injection (Toradol, Syntex)
Loading Dose:
Maintenance Dose:

Maximum Daily Dose:

30 or 60mg IM
50% of loading dose I.M. Q6H on regular schedule. Dose
adjustment should be made for patients> 65 years old; < 50Kg;
Renal dysfunction.
Not more than 150mg on day one and 120mg thereafter.

Contraindications:

Those typical of Prostaglandin inhibitors.

Length of Therapy:

Ketorolac should be discontinued once patients are able to
tolerate oral therapy or up to 48 hours postoperatively.

Editor's Note:

Ketorolac may be given IV push over 5 minutes when in the
Physician's judgement it may be advantageous. This route has
not yet been approved by the FDA. There is considerable data
demonstrating the safety of IV administration and the
manufacturer is awaiting FDA approval to include this route in
the package insert.

• •
J.arget A ntt"blOtlCS

rr_

Usage of Aztreonam, Ampicillin/Sulbactam
(Unasyn), Ceftazidime, Ceftriaxone and
Ciprofloxacin was reviewed by the Commit-

tee. The review will continue and will be
discussed at the November meeting. Usage is
reviewed against guidelines on the back of the
Antibiotic Order Sheet. Additionally, the
Committee was updated on Antibiotic costs
to da\..!.

Antibiotic Cost Report
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Adverse Drug
leaction (ADR)
Report

The Good, The Bad and the Probable
The Committee was updated on ADR's
reported to Pharmacy between April and
August, 1992. 113 reports were received with
9 reactions being interpreted as Severe. (See
table for detail). EditJJr's note: Reactions are

Severe Reactions:

reported using the ADRform (Form #PHM-9 5).
They are typed according to whether the reactilm is
an extension ofphfJT'l11aCQ/ogic effect or idiosyncratic and rankedfor severity. Finally they are
rated in terms ofprobability using an accepted
rating systmt.

Agent

Reaction

Probability

Procainamide SR

V.Tach. - Torsade de Pointes
Recurrent NSVT

Probable

Astemizole (Hismanal)

Torsade de Pointes

Probable

Heparin

Thrombocytopenia/Thrombosis
(White Clot Syndrome)

Probable

Contrast Dye

Acute Tubular Necrosis

Possible

Gentamicin

Nephrotoxicity

Possible

Succinylcholine

Muscle Fasciculations/
Rha bdomyolysis

Probable

Flecainide

Cardiac Arrest (Brady Arrest/VT)

Probable

Hydrochlorothiazide

Respiratory Distress

Probable

What~ In/What~ Out
The Committee was informed that Pharmacy
is able to obtain sufficient quantities of
Procblarperazine lnjectian (Compazine) to
fill all orders. The injectable formulation of
this agent was unavailable due to a raw
material shortage by the manufacturer.
Additionally, the Committee was notified that
Adenosine Injection (Adenocard) is unavailable. All use for Adenosine-Thallium Stress

tests has been suspended to conserve the
remaining supply for emergency management
of SVf. Other agents are available to conduct Pharmacologic Stress Tests. For
information, please contact a Clinical Pharmacist or Nuclear Medicine Physician. Once
Adenosine supplies are available from the
manufacturer, Adenosine Stress Tests will
again be scheduled.
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DATE:

TO:
FROM:

RE:

Memorandum
November 10, 1992
Members of the Medical Staff
Charles A. Gordon, M.D.
Physician liS Liaison
PHAMIS LastWord
PHAMIS is coming the first or second quarter of 1993. Your patients' complete
and up-to-the-minute lab results, transcriptions, demographic, and insurance
information will be available via PHAMIS.
Please take a minute to answer the following three questions so that we can
identify levels of physician users of the current HIS (Hospital Information
System). This will assist us in customizing your PHAMIS educational sessions.
1. Do you use the current HIS system?

Yes- -

No- -

2. If so, how frequently?
Daily_ _
3.

Name

Weekly_ _

Infrequently_ _

What patient information do you access (e.g., census, patient location,
lab results, etc.)

(please print)

Phone Number- - - - -

Thank you for your time and effort. Please feel free to contact me with any
PHAMIS questions or concerns at (215) 433-1366.
Please mail or Fax to:

Information Services
2024 Lehigh Street
Allentown, PA 18103
Fax Number- 402-1409
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Medical Staff

Progress Notes
John Jaffe, M.D.
President, Medical Staff
J.oseph A. Candio, M.D.
President-elect, Medical Staff
Charles J. Scagliotti, M.D.
Past President, Medical Staff
John W. Hart
Vice President
RitaM. Mest
Medical Staff Coordinator
Janet M. Laudenslager
Coordinator, Physician Office
Practice Services
Managing Editor

Medical Executive Committee
Harry W. Buchanan IV, M.D.
John E. Castaldo, M.D.
Victor J. Celani, M.D.
Robert V. Cumminga, M.D.
Carl F. D'Angelo, M.D.

Robert B. Doll, M.D.
John D. Farrell, M.D.
John P. Fitzgibbona, M.D.
Michael H. Geller, M.D.
Mark A. Gittleman, M.D.
James J. Goodreau, M.D.
Samuel R. Huston
Thomas A. Hutchinson, M.D.
Michael W. Kaufmann, M.D.
Mark C. Lester, M.D.
Ronald A. Lutz, M.D.
Alphonse A. Maffeo, M.D.
D. Lynn Morris, M.D.
Walter J. Okunski, M.D.
RobertJ. Oriel, M.D.
John J. Shane, M.D.
John D. VanBralde, M.D.
Headley S. White, M.D.
JohnS. Ziegler, D.D.S.

Medical Staff Progress
Notes is published
monthly to inform the
Lehigh Valley Hospital
Medical Staff and
employees of important
issues concerning the
Medical Staff. Articles
should be submitted to
Janet M. Laudenslager,
Coordinator, Physician
Office Practice Services,
17th & Chew, by the
f"IrSt of each month. H
you have any questions
about the newsletter,
please call Janet at
402-2780.

